Brief: SciClone Pharmaceuticals's Shareholder Reduces Stake In The Company For HK$418.9 Mln- HKEX Filing
March 15 (Reuters) - Hong Kong stock exchange filing:
* SCICLONE PHARMACEUTICALS 6600.HK SHAREHOLDER MENG LIANG
SOLD
41.64 MLN SHARES IN THE COMPANY AT AVG PRICE OF HK$10.06
($1.28) PER SHARE ON MARCH 10 - HKEX FILING
* MENG'S LONG POSITION IN SCICLONE PHARMACEUTICALS FALLS TO
10.03%
FROM 16.78% - HKEX FILING
Source text
Further company coverage: 6600.HK
($1 = 7.8497 Hong Kong dollars)
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on SciClone Pharmaceuticals (Holdings)
See all newsOneRobotics surges on plan to buy more shares
Brief: Onerobotics (Shenzhen) To Procure Affiliate Of Co To Acquire 59.9% Stake Of Nanoleaf Limited, Others
Brief: OneRobotics (Shenzhen) Says Final Offer Price Under Global Offering Is HK$73.80 Per H Share
Brief: Sciclone Pharmaceuticals (Holdings) Announces Proposal For Privatisation Of Co By Silver Pegasus Investment
Brief: SciClone Pharmaceuticals Says Trading In Shares Halted